Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: May 13, 2022

Big rise in esophageal cancers among middle-aged Americans. Between 2012 and 2019, the rate of this cancer nearly doubled among people aged 45 to 64, and the...

It's 'Kids to Parks Day': Get Out, Get Active

SATURDAY, May 21, 2022 -- It's a good idea to get children outside every day, but especially on Kids to Parks Day, a national day of outdoor play on May...

Mystery of Pediatric Hepatitis Cases Deepens as CDC Probe Continues

FRIDAY, May 20, 2022 -- Evidence continues to mount that a specific strain of adenovirus could be implicated in a wave of American children who have developed...

Mounjaro Approved for Blood Glucose Control in Type 2 Diabetes

FRIDAY, May 20, 2022 -- Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type...

Senate OKs Bill to Overhaul Infant Formula Rules

FRIDAY, May 20, 2022 -- A bill that would allow families in a U.S. government assistance program to buy whatever brand of baby formula they can find is on the...

1999 to 2019 Saw Decrease in Cancer Mortality for Blacks in the U.S.

FRIDAY, May 20, 2020 -- From 1999 to 2019, the overall cancer death rate decreased significantly among Black men and women, but in 2019, cancer death rates...

Regulatory, Patent Reform Needed for Inhalers for Asthma, COPD

FRIDAY, May 20, 2022 -- Of the 62 inhalers approved by the U.S. Food and Drug Administration since 1986, few have offered novel drug innovations, according to...

Mystery of Hepatitis Cases in Kids Deepens as CDC Probe Continues

FRIDAY, May 20, 2022 -- Evidence continues to mount that a specific strain of adenovirus could be implicated in a wave of American children who've developed...

Global Warming Could Mean Less Sleep for Billions

FRIDAY, May 20, 2022 -- Anyone who's tried to sleep on a hot summer night knows how hard it is to nod off when the mercury is rising. So it's no surprise that...

Big Rise in Marijuana Vaping Among U.S. Teens

FRIDAY, May 20, 2022 -- A growing number of U.S. teenagers are vaping marijuana -- a habit that in some ways may be more risky than old-fashioned pot smoking...

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX (tecovirimat)

NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health...

Travere Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Sparsentan for the Treatment of IgA Nephropathy

PDUFA target action date of November 17, 2022 SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the...

scPharmaceuticals Inc. Announces FDA Acceptance of Furoscix New Drug Application

PDUFA action date set for October 8, 2022 BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical...

Update on U.S. FDA Review of Biologics License Application (BLA) for Bimekizumab - Complete Response Letter

Brussels (Belgium), 13th May 2022 – UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has...

FDA Approves Mounjaro (tirzepatide) Injection for the Treatment of Adults with Type 2 Diabetes

INDIANAPOLIS, May 13, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's...

FDA Approves Radicava ORS (edaravone) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

JERSEY CITY, N.J., May 13, 2022 /PRNewswire/ -- Mitsubishi Tanabe Pharma Corporation (MTPA) today announced the U.S. Food and Drug Administration (FDA) has...

FDA Approves Olumiant (baricitinib) Treatment for COVID-19 in Certain Hospitalized Adults

INDIANAPOLIS, May 11, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today the U.S. Food and Drug Administration...

Eisai Completes Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab for Early Alzheimer’s Disease Under the Accelerated Approval Pathway

TOKYO and CAMBRIDGE, Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge...

Enhertu Approved in the US for Patients with HER2-Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen

Approval broadens indication for AstraZeneca and Daiichi Sankyo’s Enhertu to earlier use in metastatic breast cancer Based on ground-breaking...

Hutchmed Receives Complete Response Letter from the U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors

Hong Kong, Shanghai & Florham Park, NJ — Monday, May 2, 2022: Hutchmed (China) Limited (“Hutchmed” or the “Company”)...

MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal

NEW YORK, May 19, 2022,. Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company...

Pre-clinical findings support the potential use of RhoVac's drug candidate, onilcamotide, across several cancers

STOCKHOLM, May 18, 2022 , RhoVac AB ("RHOVAC") today, 18th May 2022, announces preclinical findings from its collaboration with St. John's Research Institute...

Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age

NEW YORK & MAINZ, Germany, May 17, 2022 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration...

First patient randomized in Phase 2 trial in head and neck cancer

STOCKHOLM, May 17, 2022.Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the first patient has been...

PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab

MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--May 16, 2022-- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused...

Browse by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.